{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:35:25Z","timestamp":1775277325129,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T00:00:00Z","timestamp":1551830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00467-019-04221-x","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T19:44:33Z","timestamp":1551901473000},"page":"1383-1385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Proteinuria in a patient with Graves\u2019 disease: Answers"],"prefix":"10.1007","volume":"34","author":[{"given":"Aydilek","family":"Dagdeviren Cakir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur","family":"Canpolat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seha","family":"Saygili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isin","family":"Kilicaslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hande","family":"Turan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oya","family":"Ercan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olcay","family":"Evliyaoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,6]]},"reference":[{"key":"4221_CR1","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/S0140-6736(70)91905-7","volume":"760","author":"J Churg","year":"1970","unstructured":"Churg J, Habib R, White RH (1970) Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet 760:1299\u20131302","journal-title":"Lancet"},{"key":"4221_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/ki.1978.23","volume":"13","author":"International Study of Kidney Disease in Children","year":"1978","unstructured":"International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159\u2013165","journal-title":"Kidney Int"},{"key":"4221_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF00858840","volume":"4","author":"JS Cameron","year":"1990","unstructured":"Cameron JS (1990) Membranous nephropathy in childhood and its treatment. Pediatr Nephrol 4:193\u2013198","journal-title":"Pediatr Nephrol"},{"key":"4221_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11\u201321","journal-title":"N Engl J Med"},{"key":"4221_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ki.2010.34","volume":"77","author":"LH Beck Jr","year":"2010","unstructured":"Beck LH Jr, Salant DJ (2010) Membranous nephropathy: recent travel and new roads ahead. Kidney Int 77:765\u2013770","journal-title":"Kidney Int"},{"key":"4221_CR6","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00467-013-2574-9","volume":"28","author":"LN Cossey","year":"2013","unstructured":"Cossey LN, Walker PD, Chris PL (2013) Phospholipase A2 receptor staining in pediatric idiopathic membranous glomerulopathy. Pediatr Nephrol 28:2307\u20132311","journal-title":"Pediatr Nephrol"},{"key":"4221_CR7","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/nep.12478","volume":"20","author":"V Kumar","year":"2015","unstructured":"Kumar V, Ramachandran R, Kumar A, Nada R, Suri D, Gupta A, Kohli HS, Gupta KL, Jha V (2015) Antibodies to M-type phospholipase A2 receptor in children with idiopathic membranous nephropathy. Nephrology 20:572\u2013575","journal-title":"Nephrology"},{"key":"4221_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0090-1229(76)90087-8","volume":"6","author":"FJSC O\u2019Regan","year":"1976","unstructured":"O\u2019Regan FJSC, Kaplan BS, De Chadarevian JP, Lapointe N, Drummond KN (1976) Thyroid antigen -antibody nephritis. Clin Immunol Immunopathol 6:341\u2013346","journal-title":"Clin Immunol Immunopathol"},{"key":"4221_CR9","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1056\/NEJM198105143042006","volume":"304","author":"SC Jordan","year":"1981","unstructured":"Jordan SC, Buckingham B, Sakai R, Olson D (1981) Studies of immune-complex glomerulonephritis mediated by human thyroglobulin. N Engl J Med 304:1212\u20131215","journal-title":"N Engl J Med"},{"key":"4221_CR10","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/0002-9343(79)90752-6","volume":"67","author":"F Horvath Jr","year":"1979","unstructured":"Horvath F Jr, Teague P, Gaffney EF, Mars DR, Fuller TJ (1979) Thyroid antigen associated immune complex glomerulonephritis in Graves\u2019 disease. Am J Med 67:901\u2013904","journal-title":"Am J Med"},{"key":"4221_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0090-1229(78)90104-6","volume":"9","author":"DW Ploth","year":"1978","unstructured":"Ploth DW, Fitz A, Schnetzler D, Seidenfeld J, Wilson CB (1978) Thyroglobulin-anti- thyroglobulin immune complex glomerulonephritis complicating radioiodine therapy. Clin Immunol Immunopathol 9:327\u2013334","journal-title":"Clin Immunol Immunopathol"},{"key":"4221_CR12","unstructured":"Sato Y, Sasaki M, Kan R, Osaku A, Koyama S, Shibayama S,\u00a0Sato M,\u00a0Narumiya K,\u00a0Takagi T,\u00a0Kojima M\u00a0\u00a0(1989) Thyroid antigen-mediated glomerulonephritis in Graves\u2019 disease. Clin Nephrol 31:49\u201352"},{"key":"4221_CR13","doi-asserted-by":"crossref","unstructured":"Shima Y, Nakanishi K, Togawa H, Obana M, Sako M, Miyawaki M,\u00a0Nozu K,\u00a0Iijima K,\u00a0Yoshikawa\u00a0N (2009) Membranous nephropathy associated with thyroid peroxidase antigen. Pediatr Nephrol 24:605\u2013608","DOI":"10.1007\/s00467-008-0973-0"},{"key":"4221_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s13730-013-0093-y","volume":"3","author":"K Sasaki","year":"2014","unstructured":"Sasaki K, Yasuda K, Nakanishi K, Rakugi H, Isaka Y, Yamato M (2014) Membranous nephropathy secondary to Graves\u2019 disease with deposits of thyroid peroxidase in an adult. CEN Case Rep 3:90\u201393","journal-title":"CEN Case Rep"},{"issue":"10","key":"4221_CR15","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1515\/jpem-2018-0186","volume":"31","author":"W Keenswijk","year":"2018","unstructured":"Keenswijk W, Degraeuwe E, Hoorens A, Dorpe JV, Vande Walle J (2018) A case of Graves\u2019 disease associated with membranoproliferative glomerulonephritis and leukocytoclastic vasculitis. J Pediatr Endocrinol Metab 31(10):1165\u20131168","journal-title":"J Pediatr Endocrinol Metab"},{"key":"4221_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/1752-1947-8-305","volume":"8","author":"Y Shimamura","year":"2014","unstructured":"Shimamura Y, Tsushima T, Moniwa N, Hasegawa K, Ogawa Y, Takizawa H (2014) Tubulointerstitial nephritis and uveitis syndrome complicated by IgA nephropathy and Graves\u2019 disease: a case report. J Med Case Rep 8:305","journal-title":"J Med Case Rep"},{"key":"4221_CR17","first-page":"96","volume":"4","author":"W Hasnain","year":"2011","unstructured":"Hasnain W, Stillman IE, Bayliss GP (2011) Minimal- change renal disease and Graves\u2019 disease: a case report and literature review. NDT Plus 4:96\u201398","journal-title":"NDT Plus"},{"key":"4221_CR18","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S0022-3476(05)83199-3","volume":"124","author":"BA Vogt","year":"1994","unstructured":"Vogt BA, Kim Y, Jennette JC, Falk RJ, Burke BA, Sinaiko A (1994) Antineutrophil cystoplasmic autoantibody\u2013positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr 124:986\u2013988","journal-title":"J Pediatr"},{"key":"4221_CR19","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1093\/rheumatology\/34.11.1090","volume":"34","author":"D D\u2019Cruz","year":"1995","unstructured":"D\u2019Cruz D, Chesser AM, Lightowler C, Comer M, Hurst MJ, Baker LR, Raine AE (1995) Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment. Br J Rheumatol 34:1090\u20131091","journal-title":"Br J Rheumatol"},{"key":"4221_CR20","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1159\/000189486","volume":"74","author":"Y Hori","year":"1996","unstructured":"Hori Y, Arizono K, Hara S, Kawai R, Hara M, Yamada A (1996) Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis associated with thiamazole therapy. Nephron 74:734\u2013735","journal-title":"Nephron"},{"key":"4221_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/0961203312467668","volume":"22","author":"S Lionaki","year":"2013","unstructured":"Lionaki S, Vlachopanos G, Georgalis A, Ziakas P, Gakiopoulou H, Petra C, Boletis J (2013) Lupus nephritis and non-Hodgkin lymphoma simultaneously diagnosed in a patient on methimazole. Lupus 22:95\u201398","journal-title":"Lupus"},{"key":"4221_CR22","first-page":"278","volume":"36","author":"LC Wang","year":"2003","unstructured":"Wang LC, Tsai WY, Yang YH, Chiang BL (2003) Methimazole-induced lupus erythematosus: a case report. J Microbiol Immunol Infect 36:278\u2013281","journal-title":"J Microbiol Immunol Infect"},{"key":"4221_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1001\/archinte.1979.03630390088030","volume":"139","author":"LR Reynolds","year":"1979","unstructured":"Reynolds LR, Bhathena D (1979) Nephrotic syndrome associated with methimazole therapy. Arch Intern Med 139:236\u2013237","journal-title":"Arch Intern Med"},{"key":"4221_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00467-013-2717-z","volume":"30","author":"R Ayalon","year":"2015","unstructured":"Ayalon R, Beck LH (2015) Membranous nephropathy: not just a disease for adults. Pediatr Nephrol 30:31\u201339","journal-title":"Pediatr Nephrol"},{"key":"4221_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/kisup.2012.9","volume":"2","author":"Kidney Disease Improving global outcomes (KDIGO) glomerulonephritis work group","year":"2012","unstructured":"Kidney Disease Improving global outcomes (KDIGO) glomerulonephritis work group (2012) KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2:139\u2013274","journal-title":"Kidney Int Suppl"},{"key":"4221_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/ndt\/gfr220","volume":"27","author":"EP McQuarrie","year":"2012","unstructured":"McQuarrie EP, Stirling CM, Geddes CC (2012) Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence \u2013based therapy. Nephrol Dial Transplant 27:235\u2013242","journal-title":"Nephrol Dial Transplant"},{"key":"4221_CR27","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0140-6736(02)11042-7","volume":"360","author":"G Remuzzi","year":"2002","unstructured":"Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P (2002) Rituximab for idiopathic membranous nephropathy. Lancet 360:923\u2013924","journal-title":"Lancet"},{"key":"4221_CR28","doi-asserted-by":"crossref","unstructured":"Ruggenenti P, Chiurchiu C, Brusegan V, Abbate M, Perna A, Filippi C, Remuzzi\u00a0G (2003) Rituximab in idiopathic membranous nephropathy: a one year prospective study. J Am Soc Nephrol 14:1851\u20131857","DOI":"10.1097\/01.ASN.0000071511.35221.B3"},{"key":"4221_CR29","doi-asserted-by":"crossref","unstructured":"Fervenza FC, Abraham RS, Erickson SB, Irazabal MV, Eirin A, Specks U, Nachman PH, Bergstralh EJ, Leung N, Cosio FG, Hogan MC, Dillon JJ, Hickson LJ, Li X, Cattran DC\u00a0(2010) Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol 5:2188\u20132198","DOI":"10.2215\/CJN.05080610"},{"key":"4221_CR30","doi-asserted-by":"crossref","unstructured":"\u00a0Ruggenenti P, Cravedi P, Chianca A, Perna A, Ruggiero B, Gaspari F,\u00a0Rambaldi A,\u00a0 Maras\u00e0 M,\u00a0 Remuzzi G\u00a0(2012) Rituximab in idiopathic membranous nephropathy. J Am Soc Nephrol 23:1416\u20131425","DOI":"10.1681\/ASN.2012020181"},{"key":"4221_CR31","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1600-6143.2006.01288.x","volume":"6","author":"MD Pescovitz","year":"2006","unstructured":"Pescovitz MD (2006) Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action. Am J Transplant 6:859\u2013866","journal-title":"Am J Transplant"},{"key":"4221_CR32","first-page":"645","volume":"4","author":"WO Weigle","year":"1969","unstructured":"Weigle WO, Nakamura RK (1969) Perpetuation of autoimmune thyroiditis and production of secondary renal lesions following periodic injections of aqueous preparations of altered thyroglobulin. Clin Exp Immunol 4:645\u2013657","journal-title":"Clin Exp Immunol"},{"key":"4221_CR33","doi-asserted-by":"crossref","unstructured":"Polanco N, Gutierrez E, Covarsi A, Ariza F, Carreno A, Vigil A, \u00a0Baltar J, Fresnedo GF, Mart\u00edn C, Pons S,\u00a0 Lorenzo D,\u00a0 Bernis C, Arrizabalaga P, Ju\u00e1rez GF, Barrio V,\u00a0 Sierra M, Castellanos I, Espinosa M, Rivera F, Oliet A,Vega FF, Praga M(2010) Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol 21:697\u2013704","DOI":"10.1681\/ASN.2009080861"},{"key":"4221_CR34","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1681\/ASN.2016070776","volume":"28","author":"AS Vriese De","year":"2017","unstructured":"De Vriese AS, Glassock RJ, Nath KA, Sethi S, Fervenza FC (2017) A proposal for a serology-based approach to membranous nephropathy. J Am Soc Nephrol 28:421\u2013430","journal-title":"J Am Soc Nephrol"},{"key":"4221_CR35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2215\/CJN.04321007","volume":"3","author":"FC Fervenza","year":"2008","unstructured":"Fervenza FC, Sethi S, Specks U (2008) Idiopathic membranous nephropathy: diagnosis and treatment. Clin J Am Soc Nephrol 3:905\u2013919","journal-title":"Clin J Am Soc Nephrol"},{"key":"4221_CR36","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/j.1523-1755.2004.00873.x","volume":"66","author":"S Troyanov","year":"2004","unstructured":"Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry Group (2004) Idiopathic membranous nephropathy: definition and relevance of a partial remission. Kidney Int 66:1199\u20131205","journal-title":"Kidney Int"},{"key":"4221_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000481635","volume":"47","author":"AS Bomback","year":"2018","unstructured":"Bomback AS, Fervenza FC (2018) Membranous nephropathy: approaches to treatment. Am J Nephrol 47:30\u201342","journal-title":"Am J Nephrol"},{"key":"4221_CR38","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00467-018-3923-5","volume":"33","author":"R Malatesta- Muncher","year":"2018","unstructured":"Malatesta- Muncher R, Eldin KW, Beck LH Jr, Michael M (2018) Idiopathic membranous nephropathy in children treated with rituximab: report of two cases. Pediatr Nephrol 33:1089\u20131092","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-019-04221-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-019-04221-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-019-04221-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:11:30Z","timestamp":1583367090000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-019-04221-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,6]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["4221"],"URL":"https:\/\/doi.org\/10.1007\/s00467-019-04221-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,6]]},"assertion":[{"value":"30 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}